Stockreport

enGene Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]

enGene Holdings Inc.  (ENGN) 
PDF Reported preliminary 6-month complete response rate (62%) in pivotal cohort patients enrolled under amended LEGEND protocol enGene selected for FDA's CDRP Program to [Read more]